These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28473243)

  • 1. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report.
    Watanabe M; Takao C; Maeda C; Nayanar G; Tominaga R; Kimura Y; Tu TTH; Nagamine T; Toyofuku A
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):464-467. PubMed ID: 38500267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.
    Grushka M; Epstein J; Mott A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):557-61. PubMed ID: 9830647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible therapeutic solution for stomatodynia (burning mouth syndrome).
    Woda A; Navez ML; Picard P; Gremeau C; Pichard-Leandri E
    J Orofac Pain; 1998; 12(4):272-8. PubMed ID: 10425973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS).
    Ko JY; Kim MJ; Lee SG; Kho HS
    Arch Gerontol Geriatr; 2012; 55(3):755-61. PubMed ID: 22040716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment modalities in burning mouth syndrome.
    Barker KE; Batstone MD; Savage NW
    Aust Dent J; 2009 Dec; 54(4):300-5; quiz 396. PubMed ID: 20415927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study.
    Amos K; Yeoh SC; Farah CS
    J Orofac Pain; 2011; 25(2):125-30. PubMed ID: 21528119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burning mouth syndrome: a systematic review of treatments.
    Liu YF; Kim Y; Yoo T; Han P; Inman JC
    Oral Dis; 2018 Apr; 24(3):325-334. PubMed ID: 28247977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study.
    Rodríguez de Rivera Campillo E; López-López J; Chimenos-Küstner E
    Bull Group Int Rech Sci Stomatol Odontol; 2010 May; 49(1):19-29. PubMed ID: 22750263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
    Paudel D; Utsunomiya M; Yoshida K; Giri S; Uehara O; Matsuoka H; Chiba I; Toyofuku A; Abiko Y
    Oral Dis; 2020 Jan; 26(1):193-199. PubMed ID: 31705718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome.
    Arduino PG; Cafaro A; Garrone M; Gambino A; Cabras M; Romagnoli E; Broccoletti R
    Lasers Med Sci; 2016 May; 31(4):811-6. PubMed ID: 26873501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study on clonazepam in patients with burning mouth syndrome.
    Heckmann SM; Kirchner E; Grushka M; Wichmann MG; Hummel T
    Laryngoscope; 2012 Apr; 122(4):813-6. PubMed ID: 22344742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions.
    Shin HI; Bang JI; Kim GJ; Kim MR; Sun DI; Kim SY
    Sci Rep; 2023 May; 13(1):7257. PubMed ID: 37142613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical amitriptyline in burning mouth syndrome: A retrospective real-world evidence study.
    Lebel A; Da Silva Vieira D; Boucher Y
    Headache; 2024 Oct; 64(9):1167-1173. PubMed ID: 39177013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis.
    Cui Y; Xu H; Chen FM; Liu JL; Jiang L; Zhou Y; Chen QM
    Oral Dis; 2016 Sep; 22(6):503-11. PubMed ID: 26680638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.
    Mitsikostas DD; Ljubisavljevic S; Deligianni CI
    J Headache Pain; 2017 Dec; 18(1):40. PubMed ID: 28357703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study.
    Kuten-Shorrer M; Treister NS; Stock S; Kelley JM; Ji YD; Woo SB; Lerman MA; Palmason S; Sonis ST; Villa A
    J Oral Facial Pain Headache; 2017 Summer; 31(3):257-263. PubMed ID: 28738111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature.
    de Moraes M; do Amaral Bezerra BA; da Rocha Neto PC; de Oliveira Soares AC; Pinto LP; de Lisboa Lopes Costa A
    J Oral Pathol Med; 2012 Apr; 41(4):281-7. PubMed ID: 22092585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amitriptyline at low dose for burning mouth syndrome.
    Nagamine T
    Oral Dis; 2024 Oct; 30(7):4650-4652. PubMed ID: 38622839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.